$2.10
Today
as of Jul 22, 16:47 ET
Last 30 days
Recent Press Releases & News
Cadrenal Therapeutics Launches Partnering Process as Its Cardiac Acute Critical Care Assets Advance to Transaction Readiness Following Landmark ISTH Data Presentation
Cadrenal Therapeutics’ Late-Breaking Phase 2 Data Demonstrate Greater Than 25% Reduction in Thrombotic Events in HIT for First-in-Class 12-LOX Inhibitor CAD-1005 at ISTH 2026 Congress
Cadrenal Therapeutics Prices Private Placement for Up to $8.8 Million
Overview
52-week range
$4.14
$16
0% of range
Avg surprise (last 3)
-4.4%
Avg reaction (last 2)
-3.6%
0% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 7, 2026 | Mar/2026 | $-1.04 | $-1.51 | +31.1% | +50.2% | -2.4% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-1.31 | — | — | — | — | financials |
| Mon Aug 11, 2025 | Jun/2025 | $-1.87 | $-1.60 | -16.9% | — | — | earnings |
| Thu May 8, 2025 | Mar/2025 | $-2.09 | $-1.64 | -27.4% | — | -4.8% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-2.18 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-2.24 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-1.56 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-1.01 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.09 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Mon Aug 10, 2026 | Jun/2026 | OTHER | -$1.55 | -$1.87 | +17.1% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-3M | — | $-3M | $-4M | $-4M | — | $-2M | $-2M |
| Net income | $-2M | — | $-3M | $-4M | $-4M | — | $-2M | $-2M |
| EPS (diluted) | $-1.04 | — | $-1.31 | $-1.87 | $-2.09 | — | $-2.18 | $-2.24 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $2M | $4M | $4M | $6M | $7M | $10M | $4M | $5M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $3M | $4M | $4M | $6M | $8M | $10M | $5M | $5M |
| Total assets | $3M | $4M | $4M | $6M | $8M | $10M | $5M | $5M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $1M | $2M | $1M | $2M | $2M | $3M | $1M | $1M |
| Total equity | $2M | $3M | $3M | $4M | $6M | $7M | $3M | $4M |
Implied volatility — last 90 days
No IV snapshots yet for CVKD.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.